IQCF6 inhibitors are a class of chemical compounds designed to specifically interfere with the function of the IQCF6 protein. IQCF6, a member of the IQ motif-containing family of proteins, is involved in regulating calcium binding and signaling processes, which are critical for a wide array of cellular functions. The IQ motif is known to mediate interactions with calmodulin and other proteins in a calcium-dependent manner, playing a significant role in signal transduction and cellular homeostasis. Inhibitors of IQCF6 are developed to block its interaction with other cellular components, thereby modulating the calcium-dependent pathways it regulates. These inhibitors are typically small molecules that fit into the binding pockets of the protein, disrupting its ability to bind to calmodulin or other partners.
The structure of IQCF6 inhibitors often mimics the regions of proteins that naturally interact with the IQCF6 protein, enabling them to competitively bind to its active or regulatory sites. They may also stabilize an inactive conformation of the protein, preventing it from participating in calcium signaling cascades. Given the importance of calcium signaling in diverse cellular processes, IQCF6 inhibitors can have a significant impact on multiple biological pathways. The development of these inhibitors requires a deep understanding of both the structural biology of IQCF6 and the dynamics of calcium-dependent protein interactions. Structural studies, including crystallography and molecular docking, are often employed to design these inhibitors with high specificity and affinity for IQCF6, ensuring that they selectively target this protein without off-target effects on other calcium-binding proteins.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A broad-spectrum kinase inhibitor, potentially affecting various cellular signaling pathways. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR, a kinase involved in many cellular processes, possibly impacting protein expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor, potentially influencing signaling pathways related to protein expression and function. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Another PI3K inhibitor, known to affect signaling pathways that influence protein expression and activity. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Inhibits protein synthesis, potentially affecting the overall expression of proteins including IQCF6. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Disrupts protein transport within cells, potentially impacting protein processing and function. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor, could influence protein degradation and turnover. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Inhibits autophagy, potentially affecting protein degradation and cellular homeostasis. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $67.00 $156.00 | 16 | |
An HSP90 inhibitor, potentially affecting protein folding and stability. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
A MEK inhibitor, could indirectly influence signaling pathways and protein functions. | ||||||